Feature | August 20, 2013

Elekta's Leksell Gamma Knife Perfexion and Elekta Infinity Place First and Second in 2013 KLAS Radiation Therapy Report

Report cites advantages of Elekta's two systems.

August 20, 2013 — With a score of 93.1 out of 100, Elekta's Leksell Gamma Knife Perfexion system earned the top ranking, receiving high marks for uptime, treatment times and planning speeds, according to KLAS research firm's recently released customer survey, Radiation Therapy 2013: Striving for Accuracy and Upgradeability.

Elekta Infinity radiation treatment system received the No. 2 ranking with a score of 87.8.

The 2013 KLAS report – based on interviews with 169 U.S. providers – states, "[Elekta] field service engineers are very available and perform effective preventive maintenance, as is evidenced by [the Perfexion system's] extremely high uptime rates." The report quotes a chief physicist respondent who says, "Leksell Gamma Knife Perfexion never has downtime. That is partly because of the almost obsessive preventive maintenance done by Elekta. The Perfexion team is really here for us."

The report also cites the rapid treatment times for patients and planning speed: "Perfexion users are very vocal about the precise treatment that works incredibly well for treating brain tumors. Because of the accuracy, the healthy tissue is not affected."

Elekta Infinity earned high scores for reliability in the study, which states, "Providers say that the excellent field support helps with the uptime, and fantastic field support is also one thing that differentiates Elekta from other vendors." A physicist surveyed about Elekta field service people says, "They are the best I have ever had in the field … the Elekta people are just way above and beyond."

The report also cites ease of use of Elekta Infinity as a positive aspect, specifically the automated features and computerization of many functions.

For more information: www.KLASresearch.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...